News and Announcements

AstraZeneca to invest $50bn in US manufacturing and R&D

By Iain Gilbert

Date: Tuesday 22 Jul 2025

(Sharecast News) - Drugmaker AstraZeneca said on Tuesday that it plans to invest $50.0bn in the US for medicines manufacturing and R&D by 2030.
AstraZeneca said its investment will support its ambition to reach $80.0bn in revenues by 2030, with 50% generated in the US, and was expected to create tens...

Sign up for free or to read the full story

Email this article to a friend

or share it with one of these popular networks:


Article Archive

Top of Page